Form 4: Tenet Healthcare Director Sells Over 1,500 Shares Under Pre-Arranged 10b5-1 Plan

Tenet Healthcare Corp. Director James L. Bierman sold 1,551 shares of common stock for approximately $165.72 per share on May 27, 2025, as part of a pre-arranged 10b5-1 trading plan.

Summary

• James L. Bierman, a Director of Tenet Healthcare Corp. (THC), reported a sale of common stock.
• On May 27, 2025, Mr. Bierman disposed of 1,551 shares of THC common stock.
• The shares were sold at a price of $165.72 per share, totaling approximately $256,947.72.
• Following this transaction, Mr. Bierman directly beneficially owns 39,884 shares of Tenet Healthcare Corp. common stock.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan, indicating it was pre-scheduled.

Sentiment

Score: 4

Explanation: The sale of shares by a director, even under a 10b5-1 plan, can be interpreted with slight negative sentiment as it reduces insider ownership, though the pre-planned nature mitigates significant concern.

Negatives

• An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces insider ownership.
• Reduction in direct beneficial ownership by a director.

Risks

• Potential for negative market perception if investors misinterpret the sale as a lack of confidence, despite it being under a 10b5-1 plan.
• Minor reduction in alignment of director's personal holdings with shareholder interests.

Future Outlook

NA

Industry Context

This is a routine insider transaction for a healthcare company. While it does not provide broad industry trends, insider activity is routinely monitored within the healthcare sector for potential signals regarding company-specific performance or outlook.

Related Party Transactions

• Sale of 1,551 shares of Tenet Healthcare Corp. common stock by Director James L. Bierman.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a minor negative signal, potentially leading to slight downward pressure or caution, though the 10b5-1 plan context reduces this impact.

Key Dates

Recommendation

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Stock Sale, James L. Bierman, Director, 10b5-1 Plan, Healthcare Stock